Lupus is an autoimmune disease where the immune system attacks its own tissues. There are two main types: discoid lupus which only affects the skin, and systemic lupus erythematosus (SLE) which can impact internal organs like the heart, lungs and kidneys. SLE is more common in women and typically develops between ages 20-45. Symptoms can include rashes, arthritis, organ inflammation and damage. The cause is unknown but genetics and environmental factors may play a role. Diagnosis involves looking for at least 4 of 11 specific clinical criteria.
Systemic Lupus Erythematosus (SLE) is an autoimmune disease where the immune system attacks its own tissues. It most commonly affects women aged 15-40. The exact causes are unknown but genetics, viruses, sunlight, and some drugs may play a role. Symptoms vary but can include rashes, joint pain, fatigue, and organ inflammation. Diagnosis involves blood tests and potentially biopsies. Treatment focuses on rest, sun protection, medications like NSAIDs, antimalarials, corticosteroids, and immunosuppressants to control disease activity and prevent organ damage. Nursing care aims to manage symptoms, prevent infections, and educate patients.
Conditions of the Blood, Immune, and Lymphatic Systemselarson62
Anaphylactic shock is a life-threatening allergic reaction that occurs when a susceptible individual is exposed to a specific antigen for a second time, triggering circulatory and respiratory problems. Mononucleosis is an acute infectious disease caused by the Epstein-Barr virus that can be transmitted through saliva and causes flu-like symptoms along with swollen lymph nodes. Hodgkin's disease is a cancer of the lymphatic cells found in lymph nodes that causes painless swelling of the lymph nodes, fever, weight loss, and other symptoms. Aplastic anemia is a severe form of anemia where the bone marrow stops producing blood cells, leading to fatigue, shortness of breath, and susceptibility to infections.
Systemic lupus erythematosus (SLE) is an autoimmune disease where the immune system attacks its own tissues, causing inflammation and damage. It is characterized by periods of disease flares and remission. Common symptoms include joint pain, rashes, and fatigue. SLE can affect many organs like the skin, lungs, heart, and kidneys. Diagnosis involves evaluating symptoms, lab tests like antinuclear antibodies, and sometimes biopsies. Treatment aims to reduce symptoms during flares and prevent organ damage using medications like corticosteroids, antimalarials, and immunosuppressants. SLE affects mostly women of childbearing age and has no known cure.
Lupus erythematosus (LE) is an autoimmune connective tissue disorder that can affect one or several organs. Circulating autoantibodies and immune complexes are due to loss of normal immune tolerance and are pathogenic. Clinical features of LE are highly variable. LE nearly always affects the skin to some degree.
Lupus is an autoimmune disease where the immune system attacks its own tissues. There are two main types: discoid lupus which only affects the skin, and systemic lupus erythematosus (SLE) which can impact internal organs like the heart, lungs and kidneys. SLE is more common in women and typically develops between ages 20-45. Symptoms can include rashes, arthritis, organ inflammation and damage. The cause is unknown but genetics and environmental factors may play a role. Diagnosis involves looking for at least 4 of 11 specific clinical criteria.
Systemic Lupus Erythematosus (SLE) is an autoimmune disease where the immune system attacks its own tissues. It most commonly affects women aged 15-40. The exact causes are unknown but genetics, viruses, sunlight, and some drugs may play a role. Symptoms vary but can include rashes, joint pain, fatigue, and organ inflammation. Diagnosis involves blood tests and potentially biopsies. Treatment focuses on rest, sun protection, medications like NSAIDs, antimalarials, corticosteroids, and immunosuppressants to control disease activity and prevent organ damage. Nursing care aims to manage symptoms, prevent infections, and educate patients.
Conditions of the Blood, Immune, and Lymphatic Systemselarson62
Anaphylactic shock is a life-threatening allergic reaction that occurs when a susceptible individual is exposed to a specific antigen for a second time, triggering circulatory and respiratory problems. Mononucleosis is an acute infectious disease caused by the Epstein-Barr virus that can be transmitted through saliva and causes flu-like symptoms along with swollen lymph nodes. Hodgkin's disease is a cancer of the lymphatic cells found in lymph nodes that causes painless swelling of the lymph nodes, fever, weight loss, and other symptoms. Aplastic anemia is a severe form of anemia where the bone marrow stops producing blood cells, leading to fatigue, shortness of breath, and susceptibility to infections.
Systemic lupus erythematosus (SLE) is an autoimmune disease where the immune system attacks its own tissues, causing inflammation and damage. It is characterized by periods of disease flares and remission. Common symptoms include joint pain, rashes, and fatigue. SLE can affect many organs like the skin, lungs, heart, and kidneys. Diagnosis involves evaluating symptoms, lab tests like antinuclear antibodies, and sometimes biopsies. Treatment aims to reduce symptoms during flares and prevent organ damage using medications like corticosteroids, antimalarials, and immunosuppressants. SLE affects mostly women of childbearing age and has no known cure.
Lupus erythematosus (LE) is an autoimmune connective tissue disorder that can affect one or several organs. Circulating autoantibodies and immune complexes are due to loss of normal immune tolerance and are pathogenic. Clinical features of LE are highly variable. LE nearly always affects the skin to some degree.
This document discusses diabetic vasculopathy and its complications. It begins by stating that diabetes is not solely an endocrine disease but also a vasculopathy. It then lists the microvascular complications of diabetes as diabetic retinopathy, nephropathy, and neuropathy and the macrovascular complications as cardiovascular, cerebrovascular, and peripheral vascular disease. The document goes on to explain the pathogenesis of diabetic vasculopathy, focusing on endothelial dysfunction and impaired endothelium-derived vasodilation due to factors like advanced glycation end products, oxidative stress, and inflammation resulting from hyperglycemia. It provides details on the mechanisms and treatment of specific microvascular complications like retinopathy, nephropathy, and neuropathy
This document discusses current and future treatment options for systemic sclerosis (SSc). It covers treatments for Raynaud's phenomenon like nifedipine, iloprost, and bosentan which aim to dilate blood vessels and improve blood flow. It also discusses immunosuppressants like cyclophosphamide and methotrexate used to treat lung disease and skin thickening. Symptoms of gastrointestinal problems, arthritis, lung fibrosis, pulmonary hypertension, and kidney disease are reviewed along with their treatment options. The document concludes by mentioning research into new treatments like rituximab and autologous stem cell transplant and the work of research groups to advance treatment of SSc.
Systemic Lupus Erythematosus (SLE) is a complex autoimmune disease. The immune system attacks the body’s cell and tissue, resulting in inflammation and tissue damage. SLE can affect any part of the body, but most often harms the heart, joints, skin, lungs, blood vessels, liver, kidney and nervous system.
Over 40 different genes predispose to SLE.
Characterized by remission and exacerbation.
Scleroderma is a chronic connective tissue disease that causes hardening of the skin. It results from an overproduction of collagen in the body's tissues. The cause is unknown but likely involves immune system problems, genetics, and environmental triggers. Scleroderma can lead to complications by scarring and reducing function of internal organs like the lungs, kidneys, and heart. It also causes problems with fingers, teeth, digestion, and sexual function.
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can affect various organs in the body. It is more common in women, especially of childbearing age, and in African Americans. The disease is characterized by autoantibody production and tissue damage caused by immune complexes. Diagnosis is based on meeting criteria from the SLICC classification system, which improved upon previous criteria. Organ manifestations include renal, neurological, cardiac, pulmonary, hematological and cutaneous involvement. Management aims to suppress symptoms and prevent organ damage through medications like glucocorticoids, antimalarials, immunosuppressants and biologics. The goal is complete remission though sustained remission is rare
This document discusses clinical manifestations of eye diseases related to diabetes mellitus. It covers xanthelasma, diabetic cataracts, and diabetic retinopathy. Diabetic retinopathy is classified as non-proliferative or proliferative and can lead to maculopathy or advanced eye disease. The pathogenesis involves hyperglycemia causing microangiopathy, cellular damage, and neovascularization. Management includes screening, investigations like fundus photography, and treatments such as anti-VEGF drugs, steroids, laser therapy, and surgery.
Systemic Lupus Erythematosus (SLE) is a multi-gene autoimmune disease caused by a combination of genetic and environmental factors. It is characterized by abnormal immune responses that result in inflammation and damage to various organs. Diagnosis requires meeting 4 out of 11 classification criteria relating to clinical symptoms and blood markers. Management aims to induce remission of acute flares, maintain improvements to suppress symptoms, and prevent organ damage. Treatment choices depend on the severity and potential reversibility of manifestations. The goal is controlling symptoms without cure since complete sustained remission is rare.
This document outlines different types of cell injury and death. It begins by defining cell injury as occurring when stress exceeds a cell's ability to adapt. Reversible cell injury involves swelling while irreversible injury involves membrane damage, ultimately leading to cell death via either necrosis or apoptosis. Necrosis is unprogrammed cell death from pathology, resulting in inflammation, while apoptosis is genetically programmed single-cell death without inflammation. Various patterns of necrosis are described, including coagulative, liquefactive, and caseous necrosis. Apoptosis involves cell and nuclear shrinkage followed by organized nuclear fragmentation and removal of apoptotic bodies by macrophages.
This PPT covers leukocytosis and includes Types of leukocytosis-Neutrophilia, eosinophilia, basophilia, lymphocytosis and monocytosis, pathophysiology of leukocytosis, symptoms of leukocytosis and diagnosis of leukocytosis
Systemic Lupus Erythematosus (SLE) is an autoimmune disease where the immune system attacks the body's own tissues and organs. It commonly causes inflammation and damage to the skin, joints, kidneys, and other organs. SLE affects women more often than men, especially during their reproductive years. The causes involve both genetic and environmental factors. Diagnosis involves laboratory tests like a complete blood count, urinalysis, and antinuclear antibody test. Treatment options include nonsteroidal anti-inflammatory drugs, antimalarial drugs, corticosteroids, immunosuppressant drugs, and biologics.
Systemic means affects multiple organs.
Lupus is the Latin word for wolf meaning disease affecting skin where the skin lesions look like wolf bite.
Erythematosus means reddening of the skin.
Systemic Lupus Erythematosus or SLE, sometimes also called just lupus is a disease that’s systemic and affects a wide variety of organs, but notably often causes red lesions on the skin.
Systemic Lupus Erythematosus(SLE) is a chronic, nonspecific autoimmune inflammatory disease that typically affects multiple organs and systems, including the skin, joints, muscles, lungs, heart, kidneys, and the CNS and circulatory system.
Individuals with SLE are noted with the production of antibodies and inflammatory responses that are mistakenly directed at their own tissue.
Systemic lupus erythematosus (SLE) is a chronic inflammatory disease that affects multiple organs. Common symptoms include fatigue, fever, arthritis, mouth ulcers, and a butterfly-shaped rash on the face. SLE is diagnosed based on 11 criteria including specific rashes, joint pain, organ inflammation, and blood abnormalities. While there is no cure for SLE, treatment focuses on reducing inflammation and protecting organs using medications like NSAIDs, corticosteroids, and hydroxychloroquine. The goal is to relieve symptoms and decrease disease activity.
Common dermatologic disorders systemic lupus erythematosusDr. Faramarz Didar
SLE or lupus is a systemic autoimmune disease (or autoimmune connective tissue disease) that can affect any part of the body.
The immune system attacks the body's cells and tissue, resulting in inflammation and tissue damage.SLE most often harms the heart, joints, skin, lungs, blood vessels, liver, kidneys, and nervous system.
Characteristic facial rash of SLE is a butterfly rash which spread from one side of nose to other side.
It is very important to diagnose this Rash and SLE in patients who attend a cosmetic Clinic in order to solve their facial disfiguration. SLE butterfly facial rash is resistant to treatment by variety of cosmetic procedures like ablative and non-ablative laser, IPL , chemical peel and PRP. The diagnosis of SLE and systemic treatment od this disease is paramount to cosmetic approach. Cosmetic practitioner should have a broad knowledge of dermatological disorder and relevant approach to them.
This document discusses systemic lupus erythematosus (SLE), an inflammatory disease that results in multisystem involvement with a varied clinical presentation. SLE is more common in women and African Americans. Genetic and environmental factors may predispose individuals to SLE. The disease is characterized by autoantibody production, immune complex formation, and tissue damage. Certain drugs can also cause a lupus-like condition. The document outlines diagnostic criteria for SLE, treatments including corticosteroids and immunosuppressants, and issues regarding prognosis and management of the disease.
This document discusses systemic lupus erythematosus (SLE), a complex autoimmune disorder with multifactorial origins. It causes activation of T and B cells leading to autoantibody production. The pathogenesis involves genetic, hormonal and environmental factors interacting to cause immune dysregulation and failure of self-tolerance. SLE can affect many organ systems and presents with a variety of clinical manifestations involving the skin, kidneys, joints, blood, and more. Diagnosis is based on identifying 4 out of 11 diagnostic criteria. Investigations help assess disease activity and organ involvement. Treatment involves immunosuppression with corticosteroids and other drugs depending on disease severity and organ involvement.
A 28-year-old female presented with a 1 month history of intermittent fever, joint pains, puffiness of her face, hands and feet, and a malar rash. Examination found enlarged lymph nodes and spleen, with a faint pericardial friction rub. Tests found proteinuria, hematologic abnormalities, and autoantibodies consistent with systemic lupus erythematosus. SLE is an autoimmune disease caused by autoantibodies against self-antigens, which can affect multiple organ systems. Presentations, investigations, and treatments were discussed.
Sickle cell disease is an inherited blood disorder caused by a mutation in the beta-globin gene of hemoglobin. This mutation causes red blood cells to take on a sickle, or crescent, shape which can block blood vessels. Common symptoms include episodes of pain, anemia, splenomegaly, and infections due to dysfunction of the spleen. The sickled cells also have a shorter lifespan which can lead to jaundice from the buildup of bilirubin.
This document discusses focal segmental glomerulosclerosis (FSGS), including its pathophysiology, causes, genetics, management, and recurrence after kidney transplantation. FSGS is caused by damage to the glomerular filtration barrier, resulting in proteinuria. It has primary and secondary forms, some of which are genetic or associated with viruses, drugs, or reduced kidney mass. Recurrence is a risk after transplantation, especially in children, and can be treated with plasma exchange and immunosuppression.
1. Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the production of auto-antibodies against components of the cell nucleus.
2. SLE affects multiple organ systems and is more common in females, with a female to male ratio of 9:1 before puberty.
3. Diagnosis of SLE requires meeting 4 out of 11 American College of Rheumatology diagnostic criteria, including at least 1 clinical and 1 immunological criterion. Common clinical manifestations include malar rash, arthritis, renal disease, and hematological abnormalities.
Mixed Connective Tissue Disease (MCTD) is an autoimmune disease with features of systemic lupus erythematosus (SLE), scleroderma, polymyositis, and rheumatoid arthritis. It is characterized by the presence of anti-U1 RNP antibodies. Common manifestations include Raynaud's phenomenon, arthritis, myositis, and lung or kidney involvement. Treatment focuses on symptoms and may include corticosteroids, immunosuppressants, and vasodilators. Prognosis is generally good, but pulmonary hypertension and interstitial lung disease can be serious complications.
This document discusses diabetic vasculopathy and its complications. It begins by stating that diabetes is not solely an endocrine disease but also a vasculopathy. It then lists the microvascular complications of diabetes as diabetic retinopathy, nephropathy, and neuropathy and the macrovascular complications as cardiovascular, cerebrovascular, and peripheral vascular disease. The document goes on to explain the pathogenesis of diabetic vasculopathy, focusing on endothelial dysfunction and impaired endothelium-derived vasodilation due to factors like advanced glycation end products, oxidative stress, and inflammation resulting from hyperglycemia. It provides details on the mechanisms and treatment of specific microvascular complications like retinopathy, nephropathy, and neuropathy
This document discusses current and future treatment options for systemic sclerosis (SSc). It covers treatments for Raynaud's phenomenon like nifedipine, iloprost, and bosentan which aim to dilate blood vessels and improve blood flow. It also discusses immunosuppressants like cyclophosphamide and methotrexate used to treat lung disease and skin thickening. Symptoms of gastrointestinal problems, arthritis, lung fibrosis, pulmonary hypertension, and kidney disease are reviewed along with their treatment options. The document concludes by mentioning research into new treatments like rituximab and autologous stem cell transplant and the work of research groups to advance treatment of SSc.
Systemic Lupus Erythematosus (SLE) is a complex autoimmune disease. The immune system attacks the body’s cell and tissue, resulting in inflammation and tissue damage. SLE can affect any part of the body, but most often harms the heart, joints, skin, lungs, blood vessels, liver, kidney and nervous system.
Over 40 different genes predispose to SLE.
Characterized by remission and exacerbation.
Scleroderma is a chronic connective tissue disease that causes hardening of the skin. It results from an overproduction of collagen in the body's tissues. The cause is unknown but likely involves immune system problems, genetics, and environmental triggers. Scleroderma can lead to complications by scarring and reducing function of internal organs like the lungs, kidneys, and heart. It also causes problems with fingers, teeth, digestion, and sexual function.
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can affect various organs in the body. It is more common in women, especially of childbearing age, and in African Americans. The disease is characterized by autoantibody production and tissue damage caused by immune complexes. Diagnosis is based on meeting criteria from the SLICC classification system, which improved upon previous criteria. Organ manifestations include renal, neurological, cardiac, pulmonary, hematological and cutaneous involvement. Management aims to suppress symptoms and prevent organ damage through medications like glucocorticoids, antimalarials, immunosuppressants and biologics. The goal is complete remission though sustained remission is rare
This document discusses clinical manifestations of eye diseases related to diabetes mellitus. It covers xanthelasma, diabetic cataracts, and diabetic retinopathy. Diabetic retinopathy is classified as non-proliferative or proliferative and can lead to maculopathy or advanced eye disease. The pathogenesis involves hyperglycemia causing microangiopathy, cellular damage, and neovascularization. Management includes screening, investigations like fundus photography, and treatments such as anti-VEGF drugs, steroids, laser therapy, and surgery.
Systemic Lupus Erythematosus (SLE) is a multi-gene autoimmune disease caused by a combination of genetic and environmental factors. It is characterized by abnormal immune responses that result in inflammation and damage to various organs. Diagnosis requires meeting 4 out of 11 classification criteria relating to clinical symptoms and blood markers. Management aims to induce remission of acute flares, maintain improvements to suppress symptoms, and prevent organ damage. Treatment choices depend on the severity and potential reversibility of manifestations. The goal is controlling symptoms without cure since complete sustained remission is rare.
This document outlines different types of cell injury and death. It begins by defining cell injury as occurring when stress exceeds a cell's ability to adapt. Reversible cell injury involves swelling while irreversible injury involves membrane damage, ultimately leading to cell death via either necrosis or apoptosis. Necrosis is unprogrammed cell death from pathology, resulting in inflammation, while apoptosis is genetically programmed single-cell death without inflammation. Various patterns of necrosis are described, including coagulative, liquefactive, and caseous necrosis. Apoptosis involves cell and nuclear shrinkage followed by organized nuclear fragmentation and removal of apoptotic bodies by macrophages.
This PPT covers leukocytosis and includes Types of leukocytosis-Neutrophilia, eosinophilia, basophilia, lymphocytosis and monocytosis, pathophysiology of leukocytosis, symptoms of leukocytosis and diagnosis of leukocytosis
Systemic Lupus Erythematosus (SLE) is an autoimmune disease where the immune system attacks the body's own tissues and organs. It commonly causes inflammation and damage to the skin, joints, kidneys, and other organs. SLE affects women more often than men, especially during their reproductive years. The causes involve both genetic and environmental factors. Diagnosis involves laboratory tests like a complete blood count, urinalysis, and antinuclear antibody test. Treatment options include nonsteroidal anti-inflammatory drugs, antimalarial drugs, corticosteroids, immunosuppressant drugs, and biologics.
Systemic means affects multiple organs.
Lupus is the Latin word for wolf meaning disease affecting skin where the skin lesions look like wolf bite.
Erythematosus means reddening of the skin.
Systemic Lupus Erythematosus or SLE, sometimes also called just lupus is a disease that’s systemic and affects a wide variety of organs, but notably often causes red lesions on the skin.
Systemic Lupus Erythematosus(SLE) is a chronic, nonspecific autoimmune inflammatory disease that typically affects multiple organs and systems, including the skin, joints, muscles, lungs, heart, kidneys, and the CNS and circulatory system.
Individuals with SLE are noted with the production of antibodies and inflammatory responses that are mistakenly directed at their own tissue.
Systemic lupus erythematosus (SLE) is a chronic inflammatory disease that affects multiple organs. Common symptoms include fatigue, fever, arthritis, mouth ulcers, and a butterfly-shaped rash on the face. SLE is diagnosed based on 11 criteria including specific rashes, joint pain, organ inflammation, and blood abnormalities. While there is no cure for SLE, treatment focuses on reducing inflammation and protecting organs using medications like NSAIDs, corticosteroids, and hydroxychloroquine. The goal is to relieve symptoms and decrease disease activity.
Common dermatologic disorders systemic lupus erythematosusDr. Faramarz Didar
SLE or lupus is a systemic autoimmune disease (or autoimmune connective tissue disease) that can affect any part of the body.
The immune system attacks the body's cells and tissue, resulting in inflammation and tissue damage.SLE most often harms the heart, joints, skin, lungs, blood vessels, liver, kidneys, and nervous system.
Characteristic facial rash of SLE is a butterfly rash which spread from one side of nose to other side.
It is very important to diagnose this Rash and SLE in patients who attend a cosmetic Clinic in order to solve their facial disfiguration. SLE butterfly facial rash is resistant to treatment by variety of cosmetic procedures like ablative and non-ablative laser, IPL , chemical peel and PRP. The diagnosis of SLE and systemic treatment od this disease is paramount to cosmetic approach. Cosmetic practitioner should have a broad knowledge of dermatological disorder and relevant approach to them.
This document discusses systemic lupus erythematosus (SLE), an inflammatory disease that results in multisystem involvement with a varied clinical presentation. SLE is more common in women and African Americans. Genetic and environmental factors may predispose individuals to SLE. The disease is characterized by autoantibody production, immune complex formation, and tissue damage. Certain drugs can also cause a lupus-like condition. The document outlines diagnostic criteria for SLE, treatments including corticosteroids and immunosuppressants, and issues regarding prognosis and management of the disease.
This document discusses systemic lupus erythematosus (SLE), a complex autoimmune disorder with multifactorial origins. It causes activation of T and B cells leading to autoantibody production. The pathogenesis involves genetic, hormonal and environmental factors interacting to cause immune dysregulation and failure of self-tolerance. SLE can affect many organ systems and presents with a variety of clinical manifestations involving the skin, kidneys, joints, blood, and more. Diagnosis is based on identifying 4 out of 11 diagnostic criteria. Investigations help assess disease activity and organ involvement. Treatment involves immunosuppression with corticosteroids and other drugs depending on disease severity and organ involvement.
A 28-year-old female presented with a 1 month history of intermittent fever, joint pains, puffiness of her face, hands and feet, and a malar rash. Examination found enlarged lymph nodes and spleen, with a faint pericardial friction rub. Tests found proteinuria, hematologic abnormalities, and autoantibodies consistent with systemic lupus erythematosus. SLE is an autoimmune disease caused by autoantibodies against self-antigens, which can affect multiple organ systems. Presentations, investigations, and treatments were discussed.
Sickle cell disease is an inherited blood disorder caused by a mutation in the beta-globin gene of hemoglobin. This mutation causes red blood cells to take on a sickle, or crescent, shape which can block blood vessels. Common symptoms include episodes of pain, anemia, splenomegaly, and infections due to dysfunction of the spleen. The sickled cells also have a shorter lifespan which can lead to jaundice from the buildup of bilirubin.
This document discusses focal segmental glomerulosclerosis (FSGS), including its pathophysiology, causes, genetics, management, and recurrence after kidney transplantation. FSGS is caused by damage to the glomerular filtration barrier, resulting in proteinuria. It has primary and secondary forms, some of which are genetic or associated with viruses, drugs, or reduced kidney mass. Recurrence is a risk after transplantation, especially in children, and can be treated with plasma exchange and immunosuppression.
1. Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the production of auto-antibodies against components of the cell nucleus.
2. SLE affects multiple organ systems and is more common in females, with a female to male ratio of 9:1 before puberty.
3. Diagnosis of SLE requires meeting 4 out of 11 American College of Rheumatology diagnostic criteria, including at least 1 clinical and 1 immunological criterion. Common clinical manifestations include malar rash, arthritis, renal disease, and hematological abnormalities.
Mixed Connective Tissue Disease (MCTD) is an autoimmune disease with features of systemic lupus erythematosus (SLE), scleroderma, polymyositis, and rheumatoid arthritis. It is characterized by the presence of anti-U1 RNP antibodies. Common manifestations include Raynaud's phenomenon, arthritis, myositis, and lung or kidney involvement. Treatment focuses on symptoms and may include corticosteroids, immunosuppressants, and vasodilators. Prognosis is generally good, but pulmonary hypertension and interstitial lung disease can be serious complications.
This document provides information on mixed connective tissue disease (MCTD). It discusses the definition, etiology, pathophysiology, diagnosis, treatment and prognosis of MCTD. MCTD is a rare autoimmune disease with overlapping features of at least two connective tissue diseases like SLE, SSc, PM and DM. It is characterized by the presence of anti-U1 RNP antibodies. Symptoms can affect multiple organ systems. Diagnosis involves assessing clinical features and antibody levels. Treatment aims to control symptoms and is tailored based on organ involvement. Prognosis varies, with some patients experiencing complete resolution while others face life-threatening complications like pulmonary hypertension.
This patient has a history of recurrent deep vein thrombosis and pregnancy losses. She presents with right calf swelling and tenderness and is found to have thrombocytopenia and a prolonged PTT. Testing reveals a positive lupus anticoagulant on two occasions more than 12 weeks apart, meeting criteria for antiphospholipid syndrome which can present as recurrent thrombosis.
Systemic sclerosis (SSc) is an autoimmune disease characterized by fibrosis of the skin and internal organs. It results from autoimmune dysfunction leading to accumulation of T cells and cytokines in the skin that stimulate collagen deposition by fibroblasts. There are two main types: limited cutaneous SSc affects only the hands and forearms, while diffuse cutaneous SSc affects the skin over much of the body. SSc most commonly affects women ages 30-50 and can involve serious complications like scleroderma renal crisis resulting in high blood pressure, kidney damage, and other symptoms. Diagnosis involves clinical signs and presence of autoantibodies, and treatment depends on complications but may include ACE inhibitors for renal problems. Mixed connect
Chronic myelogenous leukemia (CML) is a type of leukemia characterized by the Philadelphia chromosome, which fuses the BCR and ABL genes. This results in uncontrolled proliferation of granulocytes. CML typically progresses through chronic, accelerated, and blast crisis phases. The chronic phase is often asymptomatic but may include fatigue and splenomegaly. Treatment with tyrosine kinase inhibitors like imatinib has greatly improved prognosis, achieving molecular remission in some cases. Without treatment, survival is 3-5 years in chronic phase and 3-6 months in blast crisis.
Rheumatological diseases can affect the joints, skin, and internal organs. Some common types include rheumatoid arthritis, osteoarthritis, lupus, Sjogren's syndrome, and spondyloarthropathies like ankylosing spondylitis. Rheumatoid arthritis causes chronic inflammation of the synovium and can lead to joint deformity. Osteoarthritis is characterized by cartilage loss within a joint and associated bone changes. Systemic lupus erythematosus is a multi-system autoimmune disease affecting many organs, with a variety of potential manifestations.
This document provides an overview of rheumatoid arthritis (RA) and evaluating patients with rheumatic diseases. It discusses evaluating joint swelling based on distribution, acute vs chronic symptoms, and evidence of systemic inflammation. Common tests in rheumatology like joint aspiration and antibodies are also outlined. RA is introduced as a chronic inflammatory disease affecting the synovium. Diagnostic criteria, manifestations, associated syndromes, laboratory findings, and treatment options for RA are summarized. Complications of RA like atlantoaxial subluxation are also mentioned.
Scleroderma is a group of autoimmune diseases that may result in changes to the skin, blood vessels, muscles, and internal organs.
The disease can be either localized to the skin or involve other organs in addition to the skin.
Symptoms may include areas of thickened skin, stiffness, feeling tired, and poor blood flow to the fingers or toes with cold exposure.
This case involves a 12-year-old female presenting with weakness, lethargy, and inability to work for 2 months. She had her first menstrual period last month that lasted 20 days and is currently having heavy bleeding on her 15th day of this period. On examination, she has pallor and a heart murmur. Laboratory tests show microcytic anemia. The presentation is suggestive of iron deficiency anemia likely due to heavy menstrual bleeding given her family history of menorrhagia. Further workup is needed to confirm the etiology and guide treatment.
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can affect many parts of the body. It is more common in women and certain ethnic groups. Genetic and environmental factors contribute to its development by causing the immune system to attack the body's own tissues and organs. Symptoms can include joint pain, rashes, fatigue, and organ involvement. Diagnosis is based on clinical criteria and the presence of autoantibodies. Treatment involves managing symptoms with medications such as corticosteroids, antimalarials, and immunosuppressants. Lifestyle changes can also help control the disease.
This document discusses chronic myeloid leukemia (CML). It defines CML as a stem cell disease characterized by excessive blood granulocytes and the Philadelphia chromosome - a translocation between chromosomes 9 and 22. CML progresses through chronic, accelerated and blast crisis phases. Symptoms include fatigue and splenomegaly. Diagnosis involves blood tests, bone marrow biopsy and detecting the Philadelphia chromosome. Treatment includes tyrosine kinase inhibitors, interferon and chemotherapy.
This document provides an overview of Kawasaki disease, including its history, definition, epidemiology, pathogenesis, clinical features, diagnosis, differential diagnosis, complications, and treatment. Kawasaki disease is an acute febrile illness that predominantly affects children under 5 years old and can lead to coronary artery aneurysms if left untreated. It is diagnosed based on the presence of fever for at least 5 days along with four of five principal clinical features. Intravenous immunoglobulin and aspirin are the primary treatments used to reduce the risk of coronary complications.
Systemic sclerosis (SSc) is a chronic autoimmune disease characterized by fibrosis of the skin and internal organs. It can present with Raynaud's phenomenon, skin thickening, and organ involvement such as interstitial lung disease, pulmonary arterial hypertension, or scleroderma renal crisis. Treatment focuses on specific organ complications and includes calcium channel blockers, immunosuppressants, vasodilators, and ACE inhibitors. Prognosis depends on the extent and progression of organ involvement.
The patient, a 52-year-old male smoker with a history of alcoholic cirrhosis, presented with a widespread pruritic rash involving 70% of his body consistent with erythrodermic psoriasis. As the family physician's roles include making an accurate clinical diagnosis of psoriasis, taking a holistic approach to management, educating patients, and knowing treatment options including when referral is needed, the physician must determine the appropriate management for this severe case of erythrodermic psoriasis.
This document provides information on Behcet's syndrome and Sjogren's syndrome. It discusses the diagnostic criteria for Behcet's syndrome according to the 1990 International Study Group. It describes the common oral, skin, eye, neurological, and other manifestations of Behcet's syndrome. It also discusses the etiology, pathogenesis, epidemiology, and management of Sjogren's syndrome.
Collagen is the most abundant protein in mammals and plays an important structural role. There are 28 types of collagen that serve different functions. Collagen disorders can be genetic, autoimmune, or due to other causes. They commonly cause symptoms like skin rashes, fatigue, and joint/muscle pain. Major collagen disorders include Ehlers-Danlos syndrome, lupus, scleroderma, Sjogren's syndrome, and epidermolysis bullosa. Diagnosis involves tests and biopsies while treatment focuses on managing symptoms through medications, physical therapy, and lifestyle changes.
1. Systemic sclerosis is a disease characterized by abnormalities of blood vessels, fibrosis of skin and internal organs, and activation of the immune system.
2. It is classified as limited or diffuse cutaneous systemic sclerosis based on the extent of skin involvement and rate of progression.
3. Clinical features include Raynaud's phenomenon, skin thickening, joint and muscle involvement, as well as pulmonary, cardiac, gastrointestinal, and renal complications.
Rheumatoid arthritis by dr hari sharan aryalHari Aryal
Rheumatoid arthritis is an autoimmune disease characterized by inflammation of the joints. It affects small joints like those in the hands and feet. Left untreated, inflammation can lead to cartilage and bone erosion, joint destruction, and impaired function. While the exact cause is unknown, genetic and environmental factors likely play a role. Treatment aims to induce remission, preserve joint function, and repair joint damage through medications like DMARDs, steroids, NSAIDs, and surgery if needed. Complications can include deformities, pulmonary issues, neuropathy, and vasculitis if not properly managed.
ROLE OF PATHOLOGIST IN DIAGNOSIS & MANAGEMENT OF DISEASEIra Bharadwaj
A pathologist plays two key roles in patient care: diagnosis of disease and management of disease. For diagnosis, the pathologist uses laboratory tests to confirm clinical diagnoses and determine the specific cause of disease. This informs evidence-based treatment. For management, the pathologist assesses treatment effectiveness through laboratory parameters and ensures safe blood transfusions when needed through the blood bank. As an example, a pathologist would diagnose and monitor the specific cause and treatment of a patient's anemia through hematological tests.
This document discusses primary immune deficiency diseases. It covers the general features, etiology, and types of congenital immune deficiencies including defects of B lymphocytes like X-linked agammaglobulinemia and common variable immunodeficiency. It also discusses defects of T lymphocytes including severe combined immunodeficiency. Other conditions mentioned include DiGeorge syndrome, Wiskott-Aldrich syndrome, and complement deficiencies. Multiple choice questions are provided to test understanding of these conditions.
Wet gangrene occurs due to venous obstruction leading to tissue ischemia and bacterial proliferation in moist tissues. It presents as soft, swollen, foul-smelling black tissue without a clear line of demarcation. Diabetic foot gangrene results from peripheral vascular disease, neuropathy, and infection facilitated by hyperglycemia. Dry gangrene occurs from arterial insufficiency and presents as a dry, shrunken black tissue with a well-demarcated border. Gas gangrene involves Clostridium bacteria producing tissue-damaging toxins and crepitus. Prompt surgical debridement and antibiotics are critical for treatment.
This document discusses cell injury, including its definition, types, causes, and pathogenesis. It defines cell injury as a change that occurs in a cell due to external or internal factors in its environment. There are two types of cell injury - reversible and irreversible. Reversible injury is when the cell is damaged but viable, while irreversible injury means the cell is nonviable. Common causes of cell injury include hypoxia, chemicals, infections, physical factors, and genetic factors. The pathogenesis of cell injury involves mitochondrial damage, disturbances in calcium metabolism, damage to cellular membranes, DNA and proteins. Reversible injury can progress to irreversible injury when ATP production ceases, cell membranes lyse, vital proteins are absent, and vital
This document provides information about evaluating abnormalities in a semen analysis panel, including:
- The indications, sample collection/transport procedures, and normal ranges for semen volume, pH, motility, concentration, morphology, and other tests.
- How to interpret abnormalities in these parameters, such as low/high volume, pH, motility, oligospermia/azoospermia, teratozoospermia and their potential causes.
- Quality control procedures like repeat testing, and transient defects that could affect initial semen analysis results.
Four clinical cases are then presented to demonstrate applying this evaluation and interpretation of semen analysis results.
The document provides information on cerebrospinal fluid (CSF) examination including indications, collection, analysis, and findings in different conditions like meningitis. It discusses three clinical cases. For case 1, the diagnosis is bacterial meningitis based on cloudy CSF, low glucose, and high neutrophil count. Further tests would include cultures and sensitivity. For case 2, the diagnosis is viral meningitis (measles) based on clear CSF, normal glucose, and lymphocytic pleocytosis; complications include encephalitis. For case 3, the diagnosis is tuberculous meningitis based on low glucose, low chloride, and lymphocytic pleocytosis; confirmation requires microbiological tests.
A review of the growth of the Israel Genealogy Research Association Database Collection for the last 12 months. Our collection is now passed the 3 million mark and still growing. See which archives have contributed the most. See the different types of records we have, and which years have had records added. You can also see what we have for the future.
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UPRAHUL
This Dissertation explores the particular circumstances of Mirzapur, a region located in the
core of India. Mirzapur, with its varied terrains and abundant biodiversity, offers an optimal
environment for investigating the changes in vegetation cover dynamics. Our study utilizes
advanced technologies such as GIS (Geographic Information Systems) and Remote sensing to
analyze the transformations that have taken place over the course of a decade.
The complex relationship between human activities and the environment has been the focus
of extensive research and worry. As the global community grapples with swift urbanization,
population expansion, and economic progress, the effects on natural ecosystems are becoming
more evident. A crucial element of this impact is the alteration of vegetation cover, which plays a
significant role in maintaining the ecological equilibrium of our planet.Land serves as the foundation for all human activities and provides the necessary materials for
these activities. As the most crucial natural resource, its utilization by humans results in different
'Land uses,' which are determined by both human activities and the physical characteristics of the
land.
The utilization of land is impacted by human needs and environmental factors. In countries
like India, rapid population growth and the emphasis on extensive resource exploitation can lead
to significant land degradation, adversely affecting the region's land cover.
Therefore, human intervention has significantly influenced land use patterns over many
centuries, evolving its structure over time and space. In the present era, these changes have
accelerated due to factors such as agriculture and urbanization. Information regarding land use and
cover is essential for various planning and management tasks related to the Earth's surface,
providing crucial environmental data for scientific, resource management, policy purposes, and
diverse human activities.
Accurate understanding of land use and cover is imperative for the development planning
of any area. Consequently, a wide range of professionals, including earth system scientists, land
and water managers, and urban planners, are interested in obtaining data on land use and cover
changes, conversion trends, and other related patterns. The spatial dimensions of land use and
cover support policymakers and scientists in making well-informed decisions, as alterations in
these patterns indicate shifts in economic and social conditions. Monitoring such changes with the
help of Advanced technologies like Remote Sensing and Geographic Information Systems is
crucial for coordinated efforts across different administrative levels. Advanced technologies like
Remote Sensing and Geographic Information Systems
9
Changes in vegetation cover refer to variations in the distribution, composition, and overall
structure of plant communities across different temporal and spatial scales. These changes can
occur natural.
Walmart Business+ and Spark Good for Nonprofits.pdfTechSoup
"Learn about all the ways Walmart supports nonprofit organizations.
You will hear from Liz Willett, the Head of Nonprofits, and hear about what Walmart is doing to help nonprofits, including Walmart Business and Spark Good. Walmart Business+ is a new offer for nonprofits that offers discounts and also streamlines nonprofits order and expense tracking, saving time and money.
The webinar may also give some examples on how nonprofits can best leverage Walmart Business+.
The event will cover the following::
Walmart Business + (https://business.walmart.com/plus) is a new shopping experience for nonprofits, schools, and local business customers that connects an exclusive online shopping experience to stores. Benefits include free delivery and shipping, a 'Spend Analytics” feature, special discounts, deals and tax-exempt shopping.
Special TechSoup offer for a free 180 days membership, and up to $150 in discounts on eligible orders.
Spark Good (walmart.com/sparkgood) is a charitable platform that enables nonprofits to receive donations directly from customers and associates.
Answers about how you can do more with Walmart!"
Executive Directors Chat Leveraging AI for Diversity, Equity, and InclusionTechSoup
Let’s explore the intersection of technology and equity in the final session of our DEI series. Discover how AI tools, like ChatGPT, can be used to support and enhance your nonprofit's DEI initiatives. Participants will gain insights into practical AI applications and get tips for leveraging technology to advance their DEI goals.
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Dr. Vinod Kumar Kanvaria
Exploiting Artificial Intelligence for Empowering Researchers and Faculty,
International FDP on Fundamentals of Research in Social Sciences
at Integral University, Lucknow, 06.06.2024
By Dr. Vinod Kumar Kanvaria
This presentation was provided by Steph Pollock of The American Psychological Association’s Journals Program, and Damita Snow, of The American Society of Civil Engineers (ASCE), for the initial session of NISO's 2024 Training Series "DEIA in the Scholarly Landscape." Session One: 'Setting Expectations: a DEIA Primer,' was held June 6, 2024.
How to Manage Your Lost Opportunities in Odoo 17 CRMCeline George
Odoo 17 CRM allows us to track why we lose sales opportunities with "Lost Reasons." This helps analyze our sales process and identify areas for improvement. Here's how to configure lost reasons in Odoo 17 CRM
Main Java[All of the Base Concepts}.docxadhitya5119
This is part 1 of my Java Learning Journey. This Contains Custom methods, classes, constructors, packages, multithreading , try- catch block, finally block and more.
How to Make a Field Mandatory in Odoo 17Celine George
In Odoo, making a field required can be done through both Python code and XML views. When you set the required attribute to True in Python code, it makes the field required across all views where it's used. Conversely, when you set the required attribute in XML views, it makes the field required only in the context of that particular view.
it describes the bony anatomy including the femoral head , acetabulum, labrum . also discusses the capsule , ligaments . muscle that act on the hip joint and the range of motion are outlined. factors affecting hip joint stability and weight transmission through the joint are summarized.
AUTOIMMUNITY PART 3 SJOGREN'S SYNDROME & SCLERODERMA
1. PA9.7
DEFINE & DESCRIBE THE
PATHOGENESIS OF OTHER
AUTOIMMUNE DISEASES
Dr IRA BHARADWAJ
MCI TEACHER ID: PAT 2300569
KUHS FACULTY ID: M21512
2. TEXT BOOK REFRENCES
• ROBBINS BASIC PATHOLOGY
• HARSH MOHAN TEXTBOOK OF PATHOLOGY
• DAVIDSON’S PRINCIPLES AND PRACTISE OF MEDICINE
• OTHER STANDARD REFRENCES
3. SLO
• SJOGREN SYNDROME
• SCLERODERMA
• SOME OTHER AUTOIMMUNE DISEASES
[to be discussed in systemic pathology]
• QUESTIONS ON AUTOIMMUNITY
4. SJOGREN SYNDROME
Sjogren syndrome is defined as Chronic inflammation of salivary &
lacrimal glands due to autoimmune causes
• TYPES
• Secondary – associated with other autoimmune diseases
• Primary due to Autoantibodies – ANA---
• Anti ribonucleoprotein A (ARnA), SS-A, SS-B [Ro – antibody]
• Anti DNA Antibody,
• Anti HISTONE Antibody,
5. SJOGREN SYNDROME
OTHER ETIOLOGICAL FACTORS
• HLA association is weak,
• Viral infections- role of EBV, HCV, HTLV ?
MORPHOLOGY
• Glands show Inflammation, necrosis, fibrosis
CLINICAL FEATURES
• Dry eyes & mouth
• COMPLICATIONS
• Lymphoma in 40%
6. SCLERODERMA
DEFINITION
• Abnormal accumulation of fibrous tissue (sclerosis) in skin &
other organs due to autoimmunity
TYPES
• diffuse – affects multiple systems
• limited – affects only skin of fingers, forearm & face
7. SCLERODERMA
ETIOPATHOGENESIS
Role of cellular immunity: activation against unknown antigen,
causes:
• Injury to endothelial cells lining the BV & activation of
endothelial cells, leading to
• Increase in adhesion molecules &
• Migration of activated CD4+ TL in perivascular areas.
8. SCLERODERMA
• Activated CD4+T (Th2 subset) cells produce cytokines –
(PDGF, TGF & IL-13 ) which activate macrophages & increase
collagen deposition & fibrosis.
• Repeated damage of vascular endothelium leads to
endothelial proliferation & fibrosis, which narrows the
vascular lumen, resulting in ischemia
9. SCLERODERMA
Role of humoral immunity: production of anti nuclear
antibodies [ANA]
• anti-Sci 70 against DNA topoisomerase is seen specifically in
association with pulmonary fibrosis & peripheral vascular
disease
• anticentromere antibody seen in CREST syndrome
11. SCLERODERMA
MORPHOLOGY
Skin shows the following classical changes:
• Lesion begins in fingers & extends proximally
• Microscopy shows epidermal atrophy, loss of rete pegs,
atrophy of dermal appendages & dermal fibrosis, with
thickened & hyalinized blood vessels surrounded by CD4+T
cells
• Ulceration & auto amputation of terminal phalanges may
occur
Joints, GIT, kidney, lungs, CVS show features of inflammation
& fibrosis
12. SCLERODERMA
CLINICAL FEATURES
Local symptoms
• Tightness & tethering of skin starting in fingers,
• Finger movement is impaired,
• Fingers become tapered & clawed
• Lesions progress to arm, &
• Face has masked appearance &
• Mouth is small
Systemic symptoms depend on the organs affected
13. SCLERODERMA
CREST SYNDROME
• Calcinosis cutis [deposition of calcium nodules in skin]
• Raynaud's phenomena (white-blue -red coloration of terminal digits,
especially of fingers, in response to stress or cold, due to
vasoconstriction & cyanosis, followed by reactive vasodilatation as
the digits rewarm)
• Esophageal dyspepsia / dysmotility,
• Sclerodactyly [scleroderma affecting the skin of fingers only]
• Telangiectasia [dilated capillaries on the skin of face, palmar surface
of hands & mucous membranes]
• DIAGNOSIS – skin biopsy, anti centromere antibodies
14. SOME OTHER AUTOIMMUNE DISEASES
to be discussed in systemic pathology
• RHEUMATOID ARTHRITIS – DISEASE OF JOINTS
• HASHIMOTO THYROIDITIS & GRAVES DISEASE – DISEASE OF
THYROID
• POLYARTERITIS NODOSA – VASCULAR DISEASE
• ATROPHIC GASTRITIS & PERNICIOUS ANEMIA – DISEASES OF GIT
& HEMATOLOGY
15. SHORT ESSAY – CLINICAL CASE
A 26 yr old female complained of malar skin rash, pain in
hands & wrist, and fever off & on for 2 yrs. Lab reports are as
follows : Hb – 9 gm%, MCV – 90 fl, MCH – 30 pg, TLC – 3000
cells / cu mm, platelets – 1 L/cu mm, urine examination
reveals proteinuria & hematuria. Ans the following:
• What is your diagnosis & why?
• Discuss the etiopathogenesis
• Describe the morphological changes in the kidneys
• Name one confirmatory test
16. MCQ
All of the following are autoimmune disease EXCEPT
a) SLE b) Grave’s disease c) Myasthenia gravis
d) Sickle cell anemia
Diffuse proliferative glomerulonephritis, in Lupus nephritis falls under
a) Class II b) Class III c) Class IV
d) Class V
17. MCQ
A 30 year old lady presented to the outpatient department with an
Erythematous butterfly rash on her checks. Which of the following
antibodies should be assayed initially for her suspected condition
a) Anti Ds- DNA b) Anti Ro – Antibody
c) Anti centromere antibody d) Anti mitochondrial antibody
18. MCQ
The following condition is not associated with an anti- phospholipid
syndrome
a) Venous thrombosis b) Recurrent fetal loss
c) Thrombocytosis d) Neurological manifestations
19. MCQ
The following is not part of CREST syndrome:
A) Calcinosis cutis
B) Esophageal cancer
C) Telangiectasia
D) Raynaud's phenomena
20. MCQ
Antibodies most specific for CREST syndrome is
A) anti double stranded DNA
B) anti RNA
C) anti centromere
D) anti histone
22. MCQ
HLA – B27 is strongly associated with
A) Rheumatoid arthritis
B) Sclerosing spondylitis
C) SLE
D) Type 1 DM
23. MCQ
IRF5 gene controls production of
A) Interleukin 1
B) Interferon gamma
C) Interferon receptor
D) Interferon alpha
24. MCQ
IL23R gene is associated with
A) Inflammatory bowel disease [IBD]
B) Irritable bowel syndrome [IBS]
C) SLE
D) Type 1 DM
25. MCQ
A young female has tapering fingers with restricted mobility. She also
has a small mouth & pulmonary hypertension. Which of the following
antibodies should be assayed initially for her suspected condition
a) Anti Ds- DNA b) Anti Ro – Antibody
c) Anti centromere antibody d) Anti Sci-70 antibody